What is Phantom Neuro?
Phantom Neuro, an advanced neurotechnology company originating from the Johns Hopkins University School of Medicine, is at the forefront of developing the world's first minimally invasive muscle-machine interface. This groundbreaking technology is engineered to facilitate the control of advanced robotic prosthetic limbs and exoskeletons, with potential applications extending far beyond current capabilities. The company's focus on bridging the gap between biological signals and mechanical systems positions it as a key player in the rapidly evolving fields of prosthetics, robotics, and neuro-rehabilitation.
How much funding has Phantom Neuro raised?
Phantom Neuro has raised a total of $28.3M across 3 funding rounds:
Other Financing Round
$3.3M
Other Financing Round
$6M
Other Financing Round
$19M
Other Financing Round (2022): $3.3M with participation from Breakout Ventures, Capital Factory companies, Blackrock Neurotech, LionBird Ventures, and Draper Associates
Other Financing Round (2022): $6M led by Time BioVentures, Draper Associates & Breakout Ventures, LionBird Ventures, and Risk Return
Other Financing Round (2025): $19M supported by Time BioVentures, E1 ventures, R-square RiskLab, Breakout Ventures, Draper & Associates, Actual Ventures, LionBird, Ottobock, and METIS Innovative
Key Investors in Phantom Neuro
Breakout Ventures
Breakout Ventures is a venture capital firm focused on investing in transformative companies that leverage scientific innovation and technology to create new markets. With over a decade of experience, they partner with exceptional founders to scale scientific advancements into category-defining companies. Their portfolio includes firms specializing in areas such as immune-mediated disease diagnosis, sustainable biofabrication, and gene therapy. Breakout Ventures emphasizes early investment with conviction and maintains strong relationships within the industry to help their portfolio companies achieve rapid growth.
Blackrock Neurotech
Blackrock Neurotechs mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. Blackrocks precision electrode technology is at the core of many worldwide innovations in Brain-Computer Interfaces (BCI) and through neural signal processing and stimulation has enabled BCI Pioneers to walk, talk, see, hear, and feel again.
Time BioVentures
Time BioVentures is a full-spectrum healthcare and life sciences venture capital firm based in Southern California. The firm finances innovative entrepreneurs developing transformative healthcare technologies aimed at enhancing patients' quality of life. With a focus on the life sciences sector, Time BioVentures assists both asset allocators and founders in navigating complex investment opportunities. Their portfolio includes a track record of billion-dollar startups and significant medical advancements.
What's next for Phantom Neuro?
With substantial backing and a clear strategic vision, Phantom Neuro is poised for significant expansion and technological advancement. The recent major strategic investment signals a critical phase for the company, likely enabling accelerated research and development, scaling of manufacturing capabilities, and broader clinical trials. This infusion of capital will be instrumental in bringing their innovative muscle-machine interface to market, potentially revolutionizing the lives of individuals requiring advanced prosthetic and assistive technologies. The company's trajectory suggests a strong focus on translating cutting-edge neurotechnology into tangible, life-enhancing solutions.
See full Phantom Neuro company page
